FLGC צמיחת רווחי EPS רבעונית Flora Growth Corp
Flora Growth Corp. (FLGC) is scaling medical cannabinoid supplies in the US and Germany, capturing niche pharmaceutical markets. The quarterly EPS growth rate confirms the effectiveness of this model. Low costs associated with Colombian plantations ensure pricing leadership, while strict licensing barriers protect the business from competitors. The current value of 17.60 reflects the balance of the operating profit per share metric.
%20%D7%93%D7%99%D7%A0%D7%9E%D7%99%D7%A7%D7%AA%20%D7%A8%D7%95%D7%95%D7%97%20%D7%A0%D7%A7%D7%99%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%9E%D7%A9%D7%A0%D7%94%20%D7%9C%D7%A9%D7%A0%D7%94%20%D7%91%D7%A9%D7%A0%D7%99%D7%9D%20%D7%A2%D7%A9%D7%A8%20%D7%94%D7%97%D7%95%D7%93%D7%A9%D7%99%D7%9D%20%D7%94%D7%90%D7%97%D7%A8%D7%95%D7%A0%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_FLGC_-_Flora-Growth-Corp._-_Year-over-year-net-earnings-per-share-trend-for-the-last-twelve-months "FLGC - צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים floragrowth.ca בטווח 04.07.2022 - 29.01.2026 | 👁️GURU.Markets👁️")
Flora Growth Inc (FLGC) - פילוחי מדדים ודוחות פיננסיים
Quarterly EPS measures net income per share, allowing investors to differentiate real business performance from short-term market volatility through a quarterly EPS chart. Steady growth in this metric confirms that Flora Growth Corp. is capitalizing on its advantages in Europe, where licensing barriers and legalization in Germany are driving customer base expansion and strengthening the company's fundamental resilience.
